INDIANAPOLIS, April 16,
2024 /PRNewswire/ -- Eli Lilly and Company (NYSE:
LLY) will announce its first-quarter 2024 financial results on
April 30, 2024. Lilly will also
conduct a conference call that day with the investment community
and media to further detail the company's financial
performance.
The conference call will begin at 10 a.m.
Eastern time. Investors, media and the general public can
access a live webcast of the conference call through a link that
will be posted on Lilly's website at
https://investor.lilly.com/webcasts-and-presentations. A replay
will also be available on the website following the conference
call.
About Lilly
Lilly is a medicine company turning
science into healing to make life better for people around the
world. We've been pioneering life-changing discoveries for nearly
150 years, and today our medicines help more than 51 million people
across the globe. Harnessing the power of biotechnology, chemistry
and genetic medicine, our scientists are urgently advancing new
discoveries to solve some of the world's most significant health
challenges: redefining diabetes care; treating obesity and
curtailing its most devastating long-term effects; advancing the
fight against Alzheimer's disease; providing solutions to some of
the most debilitating immune system disorders; and transforming the
most difficult-to-treat cancers into manageable diseases. With each
step toward a healthier world, we're motivated by one thing: making
life better for millions more people. That includes delivering
innovative clinical trials that reflect the diversity of our world
and working to ensure our medicines are accessible and
affordable. To learn more,
visit Lilly.com and Lilly.com/news or
follow us on Facebook,
Instagram and LinkedIn. F-LLY
Refer to:
|
Jordan
Bishop; jordan.bishop@lilly.com; 317-473-5712
(Media)
|
|
Joe
Fletcher; jfletcher@lilly.com; 317-296-2884
(Investors)
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-first-quarter-2024-financial-results-announcement-302117160.html
SOURCE Eli Lilly and Company